watch

Latest Media

Warning! Third-party cookies must be enabled to view SlideShare presentations. ×

Having trouble?

2012 R&D Council of NJ Bristol-Myers Squibb Edison Patent Award Film

Bristol-Myers Squibb Co. video

2012 R&D Council of NJ Bristol-Myers Squibb Edison Patent Award Film

Bristol-Myers Squibb Co. video

Bristol-Myers Squibb Reports Mixed Estimates For Q4

Bristol-Myers Squibb Co. video

Bristol-Myers Squibb Technical Operation Italy

Executives

Lamberto Andreotti, Chief Executive Officer
Lamberto Andreotti was designated chief executive officer (CEO) of the company by the Board of Directors on March 2, 2010, and officially became CEO on May 4, 2010. Prior to becoming CEO, Lamberto was president and chief operating officer responsible for all of Bristol-Myers Squibb’s pharmaceutical operations worldwide. In March 2009, Lamberto was elected to the Board of Directors.
Lamberto joined Bristol-Myers Squibb in 1998 as vice president and general manager, Italy and European Oncology. In 2000, he was named president, Europe. In November 2002, Lamberto became senior vice president and president, International. Prior to joining Bristol-Myers Squibb, Lamberto held various senior roles at other pharmaceutical companies, including Farmitalia Carlo Erba, KABI Pharmacia and Pharmacia & Upjohn.
Lamberto earned his bachelor’s degree in engineering from the University of Rome. He obtained a master’s degree from the Massachusetts Institute of Technology.
Charles Bancroft, Chief Financial Officer
Charles Bancroft was elected chief financial officer effective April 8, 2010. In this role, he is responsible for the company’s worldwide finance operations, including Tax, Treasury, Controllership area, Investor Relations, Audit Services, Financial Shared Services, Strategic Initiatives and the global commercial, R&D and manufacturing finance operations. He was appointed executive vice president of Bristol-Myers Squibb in October 2011. He has operational responsibility for Latin America, Middle East, Africa, Canada, Japan and several countries in the Pacific Rim. He reports to Lamberto Andreotti, chief executive officer.
Charlie joined Bristol-Myers in 1984 and has since held positions of increasing responsibility within the finance organization, including international assignments and senior leadership positions in the global pharmaceutical business as well as with ConvaTec. Most recently, he was vice president of Finance for the company’s global biopharmaceutical business.
Charlie received his Bachelor of Science degree in accounting from Drexel University and his Masters in Business Administration from Temple University.
Paul von Autenried, Senior Vice President, Enterprise Services and Chief Information
As senior vice president, Enterprise Services and Chief Information Officer, Paul von Autenried leads Bristol-Myers Squibb’s BioPharma IT organization, a community of information technology professionals whose work is increasingly central to the company’s BioPharma strategy and its mission of helping patients prevail over serious diseases.
Paul joined Bristol-Myers Squibb in 1996 and assumed leadership of IT in 2008. Under that leadership, the IT organization has focused on delivering enhanced tools and technologies to help teams better manage, share, and analyze a rapidly increasing amount of information, both within the company and with an extended family of external partners. These include platforms for improved collaboration, data management, data security, document management, application integration and mobility, as well as new systems in support of a more holistic customer model that focuses on the many aspects of a patient’s journey.
“The degree to which information, generated within the enterprise and created outside the company, is effectively and efficiently managed, shared, analyzed and acted upon will be the key differentiator of the next-generation BioPharma,” he says.
Prior to joining the company, Paul held positions with Kraft General Foods, Hewlett-Packard, and IBM.
He is a member of the Accenture CIO Council, Hewlett-Packard Board of Advisors, Microsoft Pharmaceutical Advisory Council, and the Research Board.
Paul holds a bachelor’s degree in electrical engineering and a master’s in computer science from Stevens Institute of Technology, and completed the program for management development at Harvard Business School.

News & Analysis

You may also be interested in: